Bradley J. Bolzon Ph.D., Director at CRISPR Therapeutics AG (CRSP), sold 60,081 shares at $150.65 ($9.2M) on 2021-06-28, disclosed to the SEC on 2021-06-30.
Open-market sale of $9.2M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.65 | 3,216 | $484K | 5.3% |
| 2 | $150.65 | 1,578 | $238K | 2.6% |
| 3 | $150.65 | 1,578 | $238K | 2.6% |
| 4 | $150.65 | 3,216 | $484K | 5.3% |
| 5 | $151.49 | 3,144 | $476K | 5.2% |
| 6 | $151.49 | 3,144 |
| $476K |
| 5.2% |
| 7 | $151.49 | 6,403 | $970K | 10.6% |
| 8 | $151.49 | 6,403 | $970K | 10.6% |
| 9 | $152.38 | 1,540 | $235K | 2.6% |
| 10 | $152.38 | 3,139 | $478K | 5.2% |
| 11 | $152.38 | 3,139 | $478K | 5.2% |
| 12 | $152.38 | 1,540 | $235K | 2.6% |
| 13 | $153.54 | 2,218 | $341K | 3.7% |
| 14 | $153.54 | 2,218 | $341K | 3.7% |
| 15 | $153.54 | 4,519 | $694K | 7.6% |
| 16 | $153.54 | 4,519 | $694K | 7.6% |
| 17 | $154.57 | 2,281 | $353K | 3.8% |
| 18 | $154.57 | 1,119 | $173K | 1.9% |
| 19 | $154.57 | 1,119 | $173K | 1.9% |
| 20 | $154.57 | 2,281 | $353K | 3.8% |
| 21 | $155.27 | 132 | $20K | 0.2% |
| 22 | $155.27 | 268 | $42K | 0.5% |
| 23 | $156.54 | 549 | $86K | 0.9% |
| 24 | $156.54 | 549 | $86K | 0.9% |
| 25 | $156.54 | 269 | $42K | 0.5% |
| Total | $152.44 avg | 60,081 | $9.2M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $14.1M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |
| CRSP | SELL | 2021-03-24 | $8.0M | — | Filing → |